查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1471966

连续血糖监测设备市场规模和预测、全球和区域份额、趋势和成长机会分析（按产品、应用、测试地点、最终用户和地理位置）

Continuous Glucose Monitoring Device Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis By Product, Application, Testing Site, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

连续血糖监测设备 (CGMD) 市场规模预计将从 2022 年的 98 亿美元增长到 2030 年的 285 亿美元。杰出参与者。

连续监测对糖尿病管理的高度重要性支撑了连续血糖监测设备的市场规模

目前，糖尿病的管理极为复杂，因为这种疾病会导致人们形成新的生活习惯、药物治疗等。此外，患有糖尿病的人需要仔细监测血糖值。由于难以维持高血糖水平，糖尿病患者对连续血糖监测设备的需求很高。这些设备是最先进的技术设备，透过感测器、发射器和监视器等组件重塑了手动糖尿病管理。凭藉其智慧功能，连续血糖监测设备为糖尿病患者提供有关血糖水平的即时更新，这有助于他们按照医疗保健医生的指示调整饮食模式或胰岛素剂量。这种即时更新降低了糖尿病患者发生低血糖或高血糖的风险。此外，近年来医疗设备产业的显着扩张，主要是在 COVID-19 大流行期间，对连续血糖监测设备的市场规模产生了积极影响。连续血糖监测设备技术的进步使糖尿病患者的生活变得更加轻鬆。例如，胰岛素管理和血糖监测已经从每天多次手指刺穿转变为在手机上滑动几次。

科技趋势

科技在糖尿病照护中发挥着至关重要的作用，因为现代技术支援各种设备和工具。连续血糖监测设备製造商瞄准的是低收入和中等收入(LMIC) 市场，而不是高收入市场，因为他们预计这些国家的糖尿病患者会转而使用连续血糖监测设备产品，特别是如果他们能够获得这些设备的良好报销的话。此外，持续监测而不是重复的自我监测有助于进一步缓解压力。与自动治疗输送系统（例如胰岛素帮浦）整合的连续血糖监测设备可以为无需根据连续血糖监测设备读数手动调整胰岛素剂量的个人带来好处。因此，连续血糖监测设备的进步可能会在未来几年带来新的连续血糖监测设备市场趋势。

连续血糖监测设备市场（按产品）：

依产品划分，市场分为感测器、发射器和接收器。到 2022 年，感测器细分市场将占据最大的连续血糖监测设备市场。 2024年1月，Dexcom宣布向美国食品药物管理局（FDA）提交名为「Stelo Glucose Sensor」的新型葡萄糖感测器的批准。这种新型感测器特别适用于为 2 型糖尿病患者设计的设备，帮助他们透过维持饮食、运动、睡眠和压力来监测健康状况。根据《中低收入国家的自我监测设备》报告，主要连续血糖监测设备供应商（雅培、Dexcom 和美敦力）的收入主要由感测器驱动。此外，患者经常喜欢使用感测器（平均每 10-14 天一次）。因此，感测器占连续血糖监测设备市场总销售收入的60-90%。

区域分析

全球连续血糖监测设备市场报告按地理位置划分为北美、欧洲、亚太地区、南美和中美洲以及中东和非洲。 2022年，北美占据最大的连续血糖监测设备市场。该地区的市场成长是由顶级公司推出的产品数量不断增加以及主要市场参与者的存在所推动的。

产业发展及未来机会：

以下列出了连续血糖监测设备市场领导者的一些策略发展：

2023 年 10 月，Philips-Medisize 宣布与 GlucoModicm 合作，将专有的非侵入性穿戴装置商业化。此次合作旨在为寻求更好监测血糖水平的糖尿病患者打造无针、准确且更实惠的解决方案。

竞争格局及重点企业：

B. Braun SE、F. Hoffmann-La-Roche Ltd、LifeScan Inc、Medtronic、Abbott Laboratories、Ypsomed Holding AG、Sensionics、Nipro Corp、GE Healthcare 和 Terumo Corp 是连续血糖监测设备市场报告中的知名公司。这些公司专注于新技术、升级现有产品和地理扩张，以满足全球不断增长的消费者需求。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解
  • 市场吸引力分析

第 3 章：研究方法

第 4 章：连续血糖监测设备市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链供应商名单

第 5 章：连续血糖监测设备市场 - 主要市场动态

  • 主要市场驱动因素
  • 主要市场限制
  • 主要市场机会
  • 未来的趋势
  • 驱动因素和限制因素的影响分析

第 6 章：连续血糖监测设备市场 - 全球市场分析

  • 连续血糖监测设备 - 全球市场概览
  • 连续血糖监测设备 - 全球市场与 2031 年预测

第 7 章：连续血糖监测设备市场 - 收入分析 - 按产品，2021-2031 年

  • 概述
  • 感应器
  • 发射机
  • 接收器

第 8 章：连续血糖监测设备市场 - 收入分析 - 按应用，2021-2031 年

  • 概述
  • 1 型糖尿病
  • 2型糖尿病

第 9 章：连续血糖监测设备市场 - 收入分析 - 按测试站点，2021-2031 年

  • 概述
  • 指尖测试
  • 备用站点测试

第 10 章：连续血糖监测设备市场 - 收入分析 - 按最终用户，2021-2031 年

  • 概述
  • 医院和诊所
  • 自我/家庭护理

第 11 章：连续血糖监测设备市场 - 收入分析，2021-2031 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

註 - 将为以下提到的地区/国家提供类似的分析

  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第13章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与专注

第 14 章：连续血糖监测设备市场 - 主要公司简介

  • B. Braun SE
  • F. Hoffmann-La-Roche Ltd
  • LifeScan Inc
  • Medtronic
  • Abbott Laboratories
  • Ypsomed Holding AG
  • Sensionics
  • Nipro Corp
  • GE Healthcare
  • Terumo Corp

第 15 章：附录

简介目录
Product Code: TIPRE00018031

The Continuous Glucose Monitoring Devices (CGMD) market size is expected to grow from US$ 9.8 billion in 2022 to US$ 28.5 billion by 2030. The Continuous Glucose Monitoring Device market report emphasizes key factors driving the Continuous Glucose Monitoring Device market growth and developments by prominent players in the market.

High Importance of Continuous Monitoring for Diabetes Management Bolsters Continuous Glucose Monitoring Device Market Size

Currently, diabetes management is extremely complex, as the disease results in people creating new lifestyle habits, medications, and so on. Moreover, people suffering from diabetes require careful monitoring of blood glucose levels. The demand for Continuous Glucose Monitoring Devices is high among diabetic people owing to the high glucose levels that are difficult to maintain. These devices are the most advanced technology devices that have reshaped manual diabetes management with their components, such as sensors, transmitters, and monitors. With their smart features, Continuous Glucose Monitoring Devices provide people with diabetes real-time updates regarding blood sugar levels, which helps them modify dietary patterns or insulin doses as directed by the healthcare physician. Such real-time updates reduce the risk of hypoglycemia or hyperglycemia among people living with diabetes. Further, significant expansion of the medical device industry in recent years, primarily during the COVID-19 pandemic, has positively impacted the Continuous Glucose Monitoring Device market size. Advancements in Continuous Glucose Monitoring Device technologies have made life easier for people with diabetes. For example, insulin administration and blood glucose monitoring have transformed from multiple finger pricks daily to a few swipes on a cell phone.

Technological Trends

Technology plays a vital role in diabetes care, as a wide range of devices and tools are enabled with modern technologies. Continuous Glucose Monitoring Device manufacturers target low- and middle-income (LMIC) markets rather than high-income markets, as they anticipate that diabetic people from these countries would switch to Continuous Glucose Monitoring Device products, particularly if they are reimbursed well for these devices. Moreover, continuous monitoring instead of repetitive self-monitoring aids in additional relief. Continuous Glucose Monitoring Devices integrated with automated treatment delivery systems (e.g., insulin pumps) can offer benefits to individuals who don't have to manually adjust insulin dosages based on Continuous Glucose Monitoring Device readings. Thus, advancements in Continuous Glucose Monitoring Devices are likely to bring new Continuous Glucose Monitoring Device market trends in the coming years.

Continuous Glucose Monitoring Devices Market, by Product:

By product, the market is segmented into sensors, transmitters, and receivers. The sensors segment held the largest Continuous Glucose Monitoring Device market share in 2022. The same segment is anticipated to register the highest CAGR of 14.6% during the forecast period. In January 2024, Dexcom announced the submission of approval for a new glucose sensor named "Stelo Glucose Sensor" to the Food and Drug Administration (FDA). The new sensor is indicated particularly for devices designed for people suffering from type 2 diabetes to help them monitor health through maintaining diet, exercise, sleep, and stress. According to the "Self-Monitoring Devices in LMICs" report, the revenue for major Continuous Glucose Monitoring Device suppliers (Abbott, Dexcom, and Medtronic) is driven primarily by sensors. Also, patients prefer sensors frequently (every 10-14 days on average). Thus, sensors account for 60-90% of the total sales revenue in the Continuous Glucose Monitoring Device market.

Regional Analysis

The global Continuous Glucose Monitoring Device market report is geographically segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest Continuous Glucose Monitoring Device market share. The market growth in this region is driven by the increasing number of product launches by top companies and the presence of key market players.

Industry Developments and Future Opportunities:

A few strategic developments by leading players operating in the Continuous Glucose Monitoring Device market are listed below:

In October 2023, Philips-Medisize announced a partnership with GlucoModicm to commercialize a proprietary noninvasive and wearable device. The partnership is aimed to create a solution that is needle-free, accurate, and more affordable for diabetic people seeking ways to monitor blood glucose levels better.

Competitive Landscape and Key Companies:

B. Braun SE, F. Hoffmann-La-Roche Ltd, LifeScan Inc, Medtronic, Abbott Laboratories, Ypsomed Holding AG, Sensionics, Nipro Corp, GE Healthcare, and Terumo Corp are the prominent companies in the Continuous Glucose Monitoring Device market report. These companies focus on new technologies, upgrading existing products, and geographic expansions to meet the growing consumer demand worldwide.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Continuous Glucose Monitoring Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Continuous Glucose Monitoring Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Continuous Glucose Monitoring Devices Market - Global Market Analysis

  • 6.1 Continuous Glucose Monitoring Devices - Global Market Overview
  • 6.2 Continuous Glucose Monitoring Devices - Global Market and Forecast to 2031

7. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million) - By Product, 2021-2031

  • 7.1 Overview
  • 7.2 Sensors
  • 7.3 Transmitters
  • 7.4 Receivers

8. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million) - By Application, 2021-2031

  • 8.1 Overview
  • 8.2 Type 1 Diabetes
  • 8.3 Type 2 Diabetes

9. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million) - By Testing Sites, 2021-2031

  • 9.1 Overview
  • 9.2 Fingertip Testing
  • 9.3 Alternate Site Testing

10. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million) - By End User, 2021-2031

  • 10.1 Overview
  • 10.2 Hospitals and Clinics
  • 10.3 Self/Homecare

11. Continuous Glucose Monitoring Devices Market - Revenue Analysis (USD Million), 2021-2031 - Geographical Analysis

  • 11.1 North America
    • 11.1.1 North America Continuous Glucose Monitoring Devices Market Overview
    • 11.1.2 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts to 2031
    • 11.1.3 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By Product
    • 11.1.4 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By Application
    • 11.1.5 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By Testing Sites
    • 11.1.6 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By End User
    • 11.1.7 North America Continuous Glucose Monitoring Devices Market Revenue and Forecasts and Analysis - By Countries
      • 11.1.7.1 United States Continuous Glucose Monitoring Devices Market
        • 11.1.7.1.1 United States Continuous Glucose Monitoring Devices Market, by Product
        • 11.1.7.1.2 United States Continuous Glucose Monitoring Devices Market, by Application
        • 11.1.7.1.3 United States Continuous Glucose Monitoring Devices Market, by Testing Sites
        • 11.1.7.1.4 United States Continuous Glucose Monitoring Devices Market, by End User
      • 11.1.7.2 Canada Continuous Glucose Monitoring Devices Market
        • 11.1.7.2.1 Canada Continuous Glucose Monitoring Devices Market, by Product
        • 11.1.7.2.2 Canada Continuous Glucose Monitoring Devices Market, by Application
        • 11.1.7.2.3 Canada Continuous Glucose Monitoring Devices Market, by Testing Sites
        • 11.1.7.2.4 Canada Continuous Glucose Monitoring Devices Market, by End User
      • 11.1.7.3 Mexico Continuous Glucose Monitoring Devices Market
        • 11.1.7.3.1 Mexico Continuous Glucose Monitoring Devices Market, by Product
        • 11.1.7.3.2 Mexico Continuous Glucose Monitoring Devices Market, by Application
        • 11.1.7.3.3 Mexico Continuous Glucose Monitoring Devices Market, by Testing Sites
        • 11.1.7.3.4 Mexico Continuous Glucose Monitoring Devices Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

  • 11.2 Europe
    • 11.2.1 Germany
    • 11.2.2 France
    • 11.2.3 Italy
    • 11.2.4 Spain
    • 11.2.5 United Kingdom
    • 11.2.6 Rest of Europe
  • 11.3 Asia-Pacific
    • 11.3.1 Australia
    • 11.3.2 China
    • 11.3.3 India
    • 11.3.4 Japan
    • 11.3.5 South Korea
    • 11.3.6 Rest of Asia-Pacific
  • 11.4 Middle East and Africa
    • 11.4.1 South Africa
    • 11.4.2 Saudi Arabia
    • 11.4.3 U.A.E
    • 11.4.4 Rest of Middle East and Africa
  • 11.5 South and Central America
    • 11.5.1 Brazil
    • 11.5.2 Argentina
    • 11.5.3 Rest of South and Central America

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Continuous Glucose Monitoring Devices Market - Key Company Profiles

  • 14.1 B. Braun SE
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 14.2 F. Hoffmann-La-Roche Ltd
  • 14.3 LifeScan Inc
  • 14.4 Medtronic
  • 14.5 Abbott Laboratories
  • 14.6 Ypsomed Holding AG
  • 14.7 Sensionics
  • 14.8 Nipro Corp
  • 14.9 GE Healthcare
  • 14.10 Terumo Corp

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud